Accelerators
NYB utilizes elite AI accelerators to transform botanical research into market-ready pharmaceutical assets. Through high-performance computing, we scale our predictive modeling to expedite lead discovery and significantly reduce R&D cycles.
Flagship Collaboration
Ignition AI Accelerator program
NYB.AI, our dedicated AI-first drug discovery subsidiary, joined the Ignition AI Accelerator—a collaboration between NVIDIA, Tribe, and Digital Industry Singapore—to scale its AI-first drug discovery. This partnership provides the high-performance computing resources necessary to accelerate research into clinical leads.
What This Collaboration Delivers
- GPU-accelerated drug-target interaction (DTI) modeling
- Technical mentorship and go-to-market scaling frameworks
